Biomanufacturing 

Many thoughtful breakdowns of Synbio 1.0 have pointed to poor product selection, the difficulty of addressing commodity markets on a venture timeframe and of retaining the data value from horizontal platforms. We at Compound feel each of those lessons ought to be internalized but that of equal if not